West Pharmaceutical Services, Inc. (WST)

West Pharmaceutical Services, Inc. (WST) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $415.56, down 0.54% on the day, which values the company at $28.95B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.

Key facts

Share price
$415.56−0.54% today
Market value
$28.95B
P/E ratio
46.6×last 12 months
Forward P/E
40.0×
Dividend yield
0.21%
Funk Score
55/100
Against its own history
Well above its usual priceusual price $284.67
200-week average
$313.9032% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

West Pharmaceutical Services, Inc. in more detail

WST trades at 46.6× its last twelve months' earnings, 40.0× next year's expected earnings, 8.5× sales. Measured against its own history, the price is 46% above what its usual multiples would imply ($284.67) — well above its usual price. It sits 32% above its 200-week average of $313.90.

Over the last five fiscal years West Pharmaceutical Services, Inc. has compounded revenue 7.4% a year, earnings per share 8.2% a year, free cash flow 9.5% a year. Its Funk Score is 55 out of 100 (financial strength 9.6, profitability 6.2, growth 4.9, value 1.3, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

3 of the superinvestors tracked here hold WST, including Bill Gates (0.5% of the portfolio), Brandon Haley (0.2% of the portfolio), Ron Baron (0.1% of the portfolio).

Superinvestors holding WST

3 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:WST vs DGX (West Pharmaceutical Services, Inc. vs Quest Diagnostics)WST vs ROIV (West Pharmaceutical Services, Inc. vs Roivant Sciences)WST vs PHG (West Pharmaceutical Services, Inc. vs Koninklijke Philips)WST vs DXCM (West Pharmaceutical Services, Inc. vs DexCom)WST vs LH (West Pharmaceutical Services, Inc. vs Labcorp Holdings)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

West Pharmaceutical Services, Inc. (WST): questions and answers

What is WST's P/E ratio?

West Pharmaceutical Services, Inc. trades at 46.6× its last twelve months' earnings and 40.0× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 15.1× to 62.0×, with a median of 38.1×.

What is WST's PEG ratio?

West Pharmaceutical Services, Inc.'s PEG ratio is 3.03 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is West Pharmaceutical Services, Inc.'s market cap?

West Pharmaceutical Services, Inc. is valued at $28.95B at a share price of $415.56.

Is WST overvalued or undervalued?

Against its own history, WST is well above its usual price: the price is 46% above the $284.67 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is WST above its 200-week moving average?

Yes. WST is 32.4% above its 200-week average of $313.90. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is West Pharmaceutical Services, Inc. growing?

Over the last five fiscal years West Pharmaceutical Services, Inc.'s revenue grew 7.4% a year and its earnings per share 8.2% a year; over ten years revenue grew 8.2% a year.

Cite this page

Funkfolio, “West Pharmaceutical Services, Inc. (WST) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/WST

Underlying data: Yahoo Finance; company filings with the SEC.